Sosnovy Bor, Russia

Aleksei Privalikhin

This inventor holds 1 USPTO granted patent. Top assignee: Reflexion Medical, Inc.. Active years: 2026.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Radiotherapy: The Contributions of Aleksei Privalikhin

Introduction

Aleksei Privalikhin is an accomplished inventor based in Sosnovy Bor, Russia. He has made significant contributions to the field of radiotherapy through his innovative patent. His work focuses on optimizing treatment time and plan quality, which is crucial for improving patient outcomes in cancer treatment.

Latest Patents

Aleksei Privalikhin holds a patent for "Methods for optimizing treatment time and plan quality for radiotherapy." This patent describes a graphical user interface that allows users to specify treatment time values and visualize the resulting dose distributions to target regions and organs-at-risk (OARs). The interface displays dose volume histograms (DVHs) that can be adjusted based on user input. This innovation enhances the ability to optimize treatment plans effectively.

Career Highlights

Aleksei is currently associated with Reflexion Medical, Inc., where he applies his expertise in radiotherapy. His work is instrumental in advancing the technology used in cancer treatment, making it more efficient and patient-friendly. With a focus on user interaction and dose optimization, he is at the forefront of medical technology innovation.

Collaborations

Aleksei collaborates with notable professionals in his field, including Yevgen Voronenko and Peter D Olcott. These partnerships enhance the development and implementation of innovative solutions in radiotherapy.

Conclusion

Aleksei Privalikhin's contributions to radiotherapy through his patent and work at Reflexion Medical, Inc. highlight the importance of innovation in medical technology. His efforts are paving the way for improved treatment options for patients undergoing cancer therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…